首页> 美国卫生研究院文献>The Journal of Physiology >Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1
【2h】

Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1

机译:靶向破坏KCNE1后小鼠的电图延长和硝苯地平可抑制的室性心律失常

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mutations in KCNE1, the gene encoding the β subunit of the slowly activating delayed rectifier potassium current (IKs) channel protein, may lead to the long QT syndrome (LQTS), a condition associated with enhanced arrhythmogenesis. Mice with homozygous deletion of the coding sequence of KCNE1 have inner ear defects strikingly similar to those seen in the corresponding human condition. The present study demonstrated and assessed the mechanism of ventricular arrhythmias in Langendorff-perfused whole heart preparations from homozygous KCNE1-/- mice compared to wild-type mice of the same age. The effects of programmed electrical stimulation with decremental pacing from the basal right ventricular epicardial surface upon electrogram waveforms recorded from the basal left ventricle were assessed and quantified using techniques of paced electrogram fractionation analysis for the first time in an experimental system. All KCNE1-/-(n = 10) but not wild-type (n = 14) mouse hearts empirically demonstrated marked pacing-induced ventricular arrhythmogenicity. This correlated with significant increases in electrogram dispersion, consistent with a wider spread in conduction velocities, in parallel with clinical findings from LQTS patients with potassium channel mutations. In contrast, introduction of 100 nM isoprenaline induced arrhythmogenicity in both KCNE1-/- (n = 7) and wild-type (n = 6) hearts during pacing. Furthermore, pretreatment with 1 μM nifedipine exerted a strong anti-arrhythmic effect in the KCNE1-/- hearts (n = 12) that persisted even in the presence of 100 nM isoprenaline (n = 6). Our findings associate KCNE1-/- with an arrhythmogenic phenotype that shows an increased dispersion of conduction velocities, and whose initiation is prevented by nifedipine, a finding that in turn may have therapeutic applications in conditions such as LQTS.
机译:编码缓慢激活的延迟整流钾电流(IKs)通道蛋白的β亚基的基因KCNE1中的突变可能导致长QT综合征(LQTS),这是与心律失常增强相关的疾病。 KCNE1编码序列纯合缺失的小鼠的内耳缺陷与在相应人类条件下观察到的内耳缺陷极为相似。本研究证明并评估了与同龄野生型小鼠相比,纯合子KCNE1-/-小鼠在Langendorff灌注的全心脏制剂中的室性心律失常的机制。在实验系统中首次使用定速心电图分级分析技术来评估和量化程序性电刺激,从右心室基底膜下表面起搏起搏对从左心室记录的电图波形的影响并进行量化。所有KCNE1-/-(n = 10),但没有野生型(n = 14)小鼠心脏凭经验显示出明显的起搏诱发的室性心律失常性。这与电描记图散布的显着增加相关,这与传导速度的更广泛分布相一致,与此同时,来自具有钾通道突变的LQTS患者的临床发现也与此相关。相反,在起搏期间,在KCNE1-/-(n = 7)和野生型(n = 6)心脏中引入100 nM异丙肾上腺素会引起心律失常。此外,用1μM硝苯地平进行的预处理在KCNE1-/-心脏(n = 12)中发挥了强大的抗心律不齐作用,即使在存在100 nM异丙肾上腺素(n = 6)的情况下,这种作用仍持续存在。我们的发现将KCNE1-/-与导致心律失常的表型联系起来,表现出传导速度的分散性增加,硝苯地平阻止了它的启动,这一发现反过来又可能在诸如LQTS的情况下具有治疗应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号